While semaglutide did not demonstrate efficacy in slowing the progression of Alzheimers disease, the extensive body of evidence supporting semaglutide continues to provide benefits for individuals with type 2 diabetes, obesity, and related comorbidities, Martin Holst Lange, chief scientific officer and executive vice president of research and development at Novo Nordisk, said in a statement
L-carnitine and fat burn More than a supplement to burn fat , L-carnitine is a substance that optimizes the cellular energy function
Compounded GLP-1s Are Not FDA-Approved Jorge Moreno, MD, an assistant professor and obesity medicine doctor at Yale Medicine in New Haven, Connecticut, says the findings highlight a broader concern that obesity specialists have about compounded versions of GLP-1 medications
Regular bone density and muscle mass assessments should be conducted in adolescents undergoing long-term treatment
Consumers should be especially wary if a seller: Offers the drug without a prescription or licensed supervision Labels the product research-grade, for research use only or not approved for human use Sells it in unusual forms such as drops, sprays or skin patches rather than injectables Encourages buyers to mix, reconstitute or split doses on their own Promotes the product to minors Fails to include clear safety warnings or usage instructions Operates from another country or sells unusually large quantities Urges customers to falsify their weight or health status to obtain the drug Consumers can report unsafe or deceptive weight-loss drug offers to the NMDOJ Consumer Protection Division at nmdoj.gov/get-help/submit-a-complaint